Tag: ILMN

  • Large Cap Most Volatile – Phillips 66 (NYSE:PSX), Illumina, Inc. (NASDAQ:ILMN), Canadian Pacific Railway (NYSE:CP), Biogen Idec (NASDAQ:BIIB)

    As the proposed rail spur extension project at the Phillips 66 (NYSE:PSX) oil refinery in Nipomo rolls forward, public concern about the plan to ship crude oil by train through San Luis Obispo County is steadily gaining momentum. The deadline for receiving responses from the public on the project’s draft environmental impact report (DEIR) was Jan. 27, and SLO County planning staffers said they received a flurry of input right before the deadline. Phillips 66 (NYSE:PSX) stock opened at $74.03 in last trading session, and closed at $74.18, trading in the range of $70.81 – $76.90. The stock showed a negative weekly performance of -3.79%.

    A slight beat on estimates coupled with a positive sales outlook from the street helped Illumina, Inc. (NASDAQ:ILMN) to gains of up to 7% in the early trading Wednesday, despite the health-care industry’s overall lackluster performance as trading got underway. Illumina’s genomic sequencing systems seem to be finding favor with customers as well as investors, although the company only narrowly beat forecasts and offered a full-year outlook range that put analyst predictions at the high end. Illumina, Inc. (NASDAQ:ILMN) shares closed at $146.67 on last trade day, by gaining 1.48%. Stock 52 week range is $48.00 – $154.99. Company’s market capitalization is $18.54 billion.

    Canadian Pacific Railway Limited (USA) (NYSE:CP) beats by $0.04, reports revs in-line; guides FY14 EPS, revs. Canadian Pacific Railway Limited (USA) (NYSE:CP)stock advanced 4.05% and finished the last session at $147.61. The EPS of the stock remained 4.11. Company’s market capitalization is $25.90 billion.

    Biogen Idec Inc. (NASDAQ:BIIB) updated its FY14 earnings guidance on Wednesday. The company provided EPS guidance of $11.00-11.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $11.65, AnalystRatings.NET reports. The company issued revenue guidance of +22-25% to ~$8.46-8.67 billion, compared to the consensus revenue estimate of $8.36 billion. Biogen Idec Inc (NASDAQ:BIIB) stock opened at $299.03 in last trading session and closed at $305.46. The 52 week range of the stock is $149.63 – $318.42 and the day range was $292.82 – $318.42.